Loading...
IQVIA Holdings Inc.
IQV•NYSE
Healthcare
Medical - Diagnostics & Research
$182.45
$-3.41(-1.83%)
IQVIA Holdings Inc. (IQV) Financial Performance & Income Statement Overview
Review IQVIA Holdings Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.81%
↑ 2.81%
Operating Income Growth
11.38%
↑ 11.38%
Net Income Growth
1.10%
↑ 1.10%
Operating Cash Flow Growth
26.38%
↑ 26.38%
Operating Margin
13.87%
↑ 13.87%
Gross Margin
34.25%
↑ 34.25%
Net Profit Margin
7.88%
↑ 7.88%
ROE
19.96%
↑ 19.96%
ROIC
10.34%
↑ 10.34%
IQVIA Holdings Inc. (IQV) Income Statement & Financial Overview
Review IQVIA Holdings Inc.'s (IQV) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.83B | $3.96B | $3.90B | $3.81B |
| Cost of Revenue | $2.53B | $2.58B | $2.52B | $2.49B |
| Gross Profit | $1.30B | $1.38B | $1.38B | $1.33B |
| Gross Profit Ratio | $0.34 | $0.35 | $0.35 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $508.00M | $453.00M | $522.00M | $509.00M |
| Operating Expenses | $802.00M | $752.00M | $828.00M | $509.00M |
| Total Costs & Expenses | $3.33B | $3.33B | $3.35B | $3.27B |
| Interest Income | $11.00M | $11.00M | $13.00M | $12.00M |
| Interest Expense | $165.00M | $171.00M | $170.00M | $163.00M |
| Depreciation & Amortization | $265.00M | $303.00M | $278.00M | $269.00M |
| EBITDA | $753.00M | $1.02B | $805.00M | $817.00M |
| EBITDA Ratio | $0.20 | $0.26 | $0.21 | $0.21 |
| Operating Income | $496.00M | $580.00M | $550.00M | $520.00M |
| Operating Income Ratio | $0.13 | $0.15 | $0.14 | $0.14 |
| Other Income/Expenses (Net) | -$173.00M | -$36.00M | -$201.00M | -$84.00M |
| Income Before Tax | $323.00M | $544.00M | $349.00M | $436.00M |
| Income Before Tax Ratio | $0.08 | $0.14 | $0.09 | $0.11 |
| Income Tax Expense | $61.00M | $112.00M | $65.00M | $75.00M |
| Net Income | $249.00M | $437.00M | $285.00M | $363.00M |
| Net Income Ratio | $0.07 | $0.11 | $0.07 | $0.10 |
| EPS | $1.42 | $2.44 | $1.57 | $1.99 |
| Diluted EPS | $1.40 | $2.42 | $1.55 | $1.97 |
| Weighted Avg Shares Outstanding | $175.70M | $178.90M | $182.10M | $182.20M |
| Weighted Avg Shares Outstanding (Diluted) | $177.40M | $180.80M | $184.20M | $184.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan